Vesalius Biocapital IV Partners is an established and reputable life-sciences venture capital firm. With a proven track record of consistent returns, we specialize in investing in best-in-class European Biopharma and HealthTech companies. Our dedicated team of experienced domain experts brings a deep scientific understanding of the life sciences field and a passion for building successful companies.

We work closely with ambitious entrepreneurs, providing progressive investments to support the development of our portfolio companies. Our approach involves carefully building a diversified portfolio across Europe, considering indication, stage, technology, and geography. In the HealthTech sector, we focus on advancing digital technology to revolutionize healthcare, leading to better diagnosis, improved patient outcomes, and reduced costs. In the Biopharma sector, we prioritize first-in-class and best-in-class drugs that address unmet needs, including novel targets, new chemical entities, biologics, and advanced therapies.

We have already completed our First Closing and are actively raising funds for Fund IV. With a target of €150M+, we aim to close 10-12 deals, investing €10-15M per deal. We hold a significant portion of our funds for follow-on investments, demonstrating our commitment to supporting the growth of our portfolio companies.

For any inquiries or further information, please contact us at [email protected] or call +352 26 84 56 82.